NewsRoom Articles - Page 57 of 592

ThursdayMar 21, 2024 4:20 pm

420 with CNW — Bipartisan Lawmakers Express Concern About Persisting Barriers to Marijuana Research

Two bipartisan Congress lawmakers have expressed serious concerns about the slow progress in implementing a measure that President Joseph Biden signed into law aimed at simplifying cannabis research procedures. Representatives Andy Harris from Maryland and Earl Blumenauer from Oregon sent a letter to the heads of the U.S. Health and Human Services (HHS) and the U.S. Drug Enforcement Administration (DEA) seeking clarification on how marijuana research should be facilitated under the Medical Marijuana and Cannabidiol Research Expansion Act signed into law by the president in 2022. Harris and Blumenauer, despite their differing views on more general marijuana policy matters, collaborated…

ThursdayMar 21, 2024 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Achieves 7% Weight Loss; Sets Stage for 8-week Diabetes and Weight Loss Animal Study

Lexaria, a global innovator in drug delivery platforms, highlighted results from its DIAB-A22-1 animal study, highlighting a 7% reduction in weight and a 19.9% reduction in blood glucose With this success, Lexaria looks to kick off its WEIGHT-A24-1 animal study to examine diabetes and weight loss effects of its patented DehydraTECH(TM)-processed GLP-1 drugs and DehydraTECH-processed CBD The study will comprise 12 arms and involve 72 animals. It will run for a total of 12 weeks This study will build on previous studies that evidenced DehydraTECH’s potential to enable greater penetration of GLP-1 drugs into the brain tissue Lexaria Bioscience (NASDAQ:…

WednesdayMar 20, 2024 4:20 pm

420 with CNW — Study Finds CBD Could Ease Stress, Irritability Linked to Menstruation

A recent study investigated the potential effects of CBD on symptoms related to menstruation, finding that oral doses of CBD helped alleviate various symptoms such as stress, anxiety and irritability compared to participants’ initial conditions. However, depression levels remained unchanged throughout the study period. The research study marks the first of its kind to explore the impact of cannabidiol specifically on menstrual-related symptoms (MRS) and general irritability. The findings indicated notable reductions in MRS, stress, irritability and anxiety after three months of CBD use compared to baseline measurements. According to the authors, the results suggest that CBD could serve as…

WednesdayMar 20, 2024 10:00 am

Congressional Committee to Hold Hearing on Psychedelics, Medical Cannabis Bills for Veterans

This week a congressional committee will be considering two measures on psychedelics and medical cannabis for military veterans. The House Veterans’ Affairs Health subcommittee will be discussing a measure that would require the veterans’ affairs department to carry out and support studies on the safety and effectiveness of forms of marijuana for post-traumatic stress disorder and chronic pain, among other eligible conditions. The measure, called the Veterans CARE Act, was sponsored by Representative Mariannette Miller-Meeks. The legislation also stipulates that the research conducted must include extracts and plants, at least three varieties of marijuana with varying concentrations of CBD and…

TuesdayMar 19, 2024 4:20 pm

420 with CNW — New Study Suggests Cannabis Handouts Could Curb Drug Overdose Fatalities

A new study published in the “Journal of Harm Reduction” proposes that distributing free marijuana through harm-reduction groups could significantly decrease drug overdose fatalities and enhance the well-being of users. The study, focusing on a cannabis donation initiative in rural Michigan, marks the pioneering documentation of the harm-reduction approach in the United States, suggesting its potential sustainability contingent upon state regulations. While acknowledging existing obstacles in marijuana distribution and regulation policies, study authors emphasize the perceived advantages recognized by harm-reduction practitioners. Those advantages include reduced premature mortality, enhanced life quality, pain alleviation, better recovery prospects and heightened safety for both…

MondayMar 18, 2024 4:20 pm

420 with CNW — How Cannabis Firms Can Prepare Themselves for Future After Rescheduling

In 2015, shortly after Colorado initiated recreational cannabis sales, marijuana operators faced a significant lesson regarding the strictness surrounding the term “organic” from state and federal authorities. Most operators had to change their business names to exclude the term. The U.S. Agriculture Department is in charge of the organic label and has accredited third-party organizations to certify farmers and their farming methods. Federal prohibition kept marijuana from receiving official organic certification at the time, and it continues to do so despite developments in licensed cannabis operations. Even so, there is a clear trend in the prevalence of cannabinoids such as…

MondayMar 18, 2024 11:00 am

Study Says More Teens Are Using Delta-8 THC Products

A new study has found that more than 11% of seniors in high school are using delta-8 THC. Delta-8 THC is one of the many compounds found in the cannabis sativa plant, of which hemp and marijuana are common varieties. This compound isn’t found in high quantities in the cannabis plant and is said to have weaker psychoactive effects in comparison to delta-9 THC. To get concentrated amounts, delta-8 THC has to be manufactured from CBD derived from hemp. It is important to note that delta-8 THC has not been approved for use and neither is it legal. Despite this,…

MondayMar 18, 2024 9:45 am

Zoned Properties Inc. (ZDPY) Seeks to Bridge the Real Estate Shortage for the U.S. Cannabis Retail Operators

Many Landlords across the United States currently face several obstacles in leasing commercial properties to cannabis-focused tenants, on the basis of ongoing federal restrictions that impact real estate factors such as insurance, financing, and permitting Zoned Properties has sought to bridge this supply gap, with a portfolio of investment properties seeking to address the needs of the regulated cannabis industry The company has recently announced plans to refocus its investment portfolio towards direct-to-consumer retail properties, simultaneously revealing their intentions to market one of their cultivation-oriented sites for sale Zoned Properties recently revealed that 3Q2023 revenues had risen by 17.2% YoY,…

MondayMar 18, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Huge 2024 Milestone with FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial

Lexaria, a global innovator in drug delivery platforms, recently received FDA clearance for its HYPER-H23-1 clinical study John Docherty, President of Lexaria, has regarded this milestone as a demonstration of its patented DehydraTECH(TM) technology’s overall viability, particularly in the potential treatment of hypertension With HYPER-H23-1, Lexaria looks to build on the success of its previous human clinical studies, whose results have been overwhelmingly positive This marks a considerable milestone even as the company looks to double down on GLP-1 studies for the 2024 calendar year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced that the…

FridayMar 15, 2024 4:20 pm

420 with CNW — Missouri Announces Date for Submission of Additional Cannabis Microbusiness Applications

The Missouri Department of Health and Senior Services (DHSS) is set to begin receiving the next wave of applications for microbusiness licenses electronically, using its online registry platform. The application window is slated to open from April 15 to April 29, 2024, with licensing expected to be finalized by July. Last year, the department granted 48 licenses for microbusiness establishments, marking the conclusion of the initial phase in a series of three rounds for the allocation of such licenses. Microbusinesses refer to licenses for cannabis facilities exclusively available to qualifying individuals and entities and are aimed at facilitating the involvement…

News and publishing service for cannabis related companies

Contact us: 512.354.7000